224 related articles for article (PubMed ID: 31118214)
21. Role of
Tang C; Zhang H; Border JJ; Liu Y; Fang X; Jefferson JR; Gregory A; Johnson C; Lee TJ; Bai S; Sharma A; Shin SM; Yu H; Roman RJ; Fan F
bioRxiv; 2023 Dec; ():. PubMed ID: 38106132
[TBL] [Abstract][Full Text] [Related]
22. VEGF autoregulates its proliferative and migratory ERK1/2 and p38 cascades by enhancing the expression of DUSP1 and DUSP5 phosphatases in endothelial cells.
Bellou S; Hink MA; Bagli E; Panopoulou E; Bastiaens PI; Murphy C; Fotsis T
Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1477-89. PubMed ID: 19741200
[TBL] [Abstract][Full Text] [Related]
23. Heterozygous knockout of transforming growth factor-β1 protects Dahl S rats against high salt-induced renal injury.
Chen CC; Geurts AM; Jacob HJ; Fan F; Roman RJ
Physiol Genomics; 2013 Feb; 45(3):110-8. PubMed ID: 23249995
[TBL] [Abstract][Full Text] [Related]
24. Dual-specificity phosphatase 5 regulates nuclear ERK activity and suppresses skin cancer by inhibiting mutant Harvey-Ras (HRasQ61L)-driven SerpinB2 expression.
Rushworth LK; Kidger AM; Delavaine L; Stewart G; van Schelven S; Davidson J; Bryant CJ; Caddye E; East P; Caunt CJ; Keyse SM
Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18267-72. PubMed ID: 25489104
[TBL] [Abstract][Full Text] [Related]
25. Renalase Protects against Renal Fibrosis by Inhibiting the Activation of the ERK Signaling Pathways.
Wu Y; Wang L; Deng D; Zhang Q; Liu W
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448446
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Park SY; Kang GH
Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
[TBL] [Abstract][Full Text] [Related]
27. Extracellular signal-regulated kinase 1/2 activation, via downregulation of mitogen-activated protein kinase phosphatase 1, mediates sex differences in desoxycorticosterone acetate-salt hypertension vascular reactivity.
Giachini FR; Sullivan JC; Lima VV; Carneiro FS; Fortes ZB; Pollock DM; Carvalho MH; Webb RC; Tostes RC
Hypertension; 2010 Jan; 55(1):172-9. PubMed ID: 19901158
[TBL] [Abstract][Full Text] [Related]
28. SIRT3-KLF15 signaling ameliorates kidney injury induced by hypertension.
Li N; Zhang J; Yan X; Zhang C; Liu H; Shan X; Li J; Yang Y; Huang C; Zhang P; Zhang Y; Bu P
Oncotarget; 2017 Jun; 8(24):39592-39604. PubMed ID: 28465484
[TBL] [Abstract][Full Text] [Related]
29. Critical role of CXCL16 in hypertensive kidney injury and fibrosis.
Xia Y; Entman ML; Wang Y
Hypertension; 2013 Dec; 62(6):1129-37. PubMed ID: 24060897
[TBL] [Abstract][Full Text] [Related]
30. Over-expression of extracellular signal-regulated kinase in vascular smooth muscle cell of hypertensive rats.
Jing L; Zhang JZ; Wang YL; Guo FY
Chin Med Sci J; 2006 Mar; 21(1):36-40. PubMed ID: 16615283
[TBL] [Abstract][Full Text] [Related]
31. Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate-salt hypertensive mice.
Rhaleb NE; Pokharel S; Sharma U; Carretero OA
J Hypertens; 2011 Feb; 29(2):330-8. PubMed ID: 21052020
[TBL] [Abstract][Full Text] [Related]
32. Intrauterine growth restriction affects hippocampal dual specificity phosphatase 5 gene expression and epigenetic characteristics.
Ke X; McKnight RA; Caprau D; O'Grady S; Fu Q; Yu X; Callaway CW; Albertine KH; Lane RH
Physiol Genomics; 2011 Oct; 43(20):1160-9. PubMed ID: 21828247
[TBL] [Abstract][Full Text] [Related]
33. p66Shc regulates renal vascular tone in hypertension-induced nephropathy.
Miller B; Palygin O; Rufanova VA; Chong A; Lazar J; Jacob HJ; Mattson D; Roman RJ; Williams JM; Cowley AW; Geurts AM; Staruschenko A; Imig JD; Sorokin A
J Clin Invest; 2016 Jul; 126(7):2533-46. PubMed ID: 27270176
[TBL] [Abstract][Full Text] [Related]
34. GLUT-1 overexpression: Link between hemodynamic and metabolic factors in glomerular injury?
Gnudi L; Viberti G; Raij L; Rodriguez V; Burt D; Cortes P; Hartley B; Thomas S; Maestrini S; Gruden G
Hypertension; 2003 Jul; 42(1):19-24. PubMed ID: 12771048
[TBL] [Abstract][Full Text] [Related]
35. Membrane rafts-redox signalling pathway contributes to renal fibrosis via modulation of the renal tubular epithelial-mesenchymal transition.
Han WQ; Xu L; Tang XF; Chen WD; Wu YJ; Gao PJ
J Physiol; 2018 Aug; 596(16):3603-3616. PubMed ID: 29863758
[TBL] [Abstract][Full Text] [Related]
36. Dual Specificity Phosphatase 5, a Specific Negative Regulator of ERK Signaling, Is Induced by Serum Response Factor and Elk-1 Transcription Factor.
Buffet C; Catelli MG; Hecale-Perlemoine K; Bricaire L; Garcia C; Gallet-Dierick A; Rodriguez S; Cormier F; Groussin L
PLoS One; 2015; 10(12):e0145484. PubMed ID: 26691724
[TBL] [Abstract][Full Text] [Related]
37. Dual-specificity phosphatase 5 acts as an anti-inflammatory regulator by inhibiting the ERK and NF-κB signaling pathways.
Seo H; Cho YC; Ju A; Lee S; Park BC; Park SG; Kim JH; Kim K; Cho S
Sci Rep; 2017 Dec; 7(1):17348. PubMed ID: 29229953
[TBL] [Abstract][Full Text] [Related]
38. Renovascular hypertension does not influence repair of glomerular lesions induced by anti-thymocyte glomerulonephritis.
Wenzel UO; Wolf G; Thaiss F; Helmchen U; Stahl RA
Kidney Int; 2000 Sep; 58(3):1135-47. PubMed ID: 10972677
[TBL] [Abstract][Full Text] [Related]
39. Macrophage differentiation of myeloid progenitor cells in response to M-CSF is regulated by the dual-specificity phosphatase DUSP5.
Grasset MF; Gobert-Gosse S; Mouchiroud G; Bourette RP
J Leukoc Biol; 2010 Jan; 87(1):127-35. PubMed ID: 19801501
[TBL] [Abstract][Full Text] [Related]
40. DUSP5 suppresses interleukin-1β-induced chondrocyte inflammation and ameliorates osteoarthritis in rats.
Wu Z; Xu L; He Y; Xu K; Chen Z; Moqbel SAA; Ma C; Jiang L; Ran J; Wu L; Zhong Y
Aging (Albany NY); 2020 Dec; 12(24):26029-26046. PubMed ID: 33361528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
